Summary. The complete sequence of the type VI dihydrofolate reductase (DHFR) gene from plasmid pUK672 was determined. The structural gene coded for a polypeptide of 157 amino acids which had a deduced mol. wt of 17 424. Comparison with amino-acid sequences of the type I, type V and Escherichia coli K12 chromosomal DHFRs showed that there was 63%, 61% and 3 1% homology respectively. Putative RNA polymerase and ribosomal binding sites were identified proximal to the initiation codon and a feature consistent with transcription termination was present distal to the coding region. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis showed that the enzyme had a subunit mol. wt of 17 500.
Introduction
High-level resistance to trimethoprim (Tp) (MIC > 1000 mg/L) is mediated by dihydrofolate reductases (DHFRs) which are resistant to the drug. The genes encoding these enzymes have been demonstrated in plasmids and transposons by which means they have also been found integrated into the bacterial chromosome.' Several such enzymes have been described in gram-negative bacteria and classified according to their biochemical properties. These are the types I(a and b), II(a, b and c), V, VI and VII. 2 The nucleotide sequences of the types I, I1 and V DHFRs have been and this has revealed considerable homology between enzymes of the same group, e.g., >78% between type IIa, b and c .~, There is no sequence homology between the type I and type 11, and the type I1 and type V genes3. ' The type V and type I DHFR genes have several similar features. Both genes code for a polypeptide of 157 amino acids and there is 75% amino-acid homology.' However, these genes do not hybridise with one another.' The type I and type V DHFR genes have regions which are homologous with the chromosomal DHFR gene of Escherichia coli Kl2. ' The type VI DHFR was originally found in Proteus rnirabilis J 120 isolated in South A f r i~a .~ It has unique biochemical properties and, so far, has been found only in that country. The mol. wt, as determined by Sephadex column chromatography, was 10 000. This suggested that it might be a functional subunit of the type I1 DHFRs (mol. wt 9500), but hybridisation experiments with a type I1 probe failed to substantiate this. l o
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This paper describes the sequence of the type VI DHFR gene and its relationship to other DHFRs.
Materials and methods

Bacterial strains
The gene encoding the type VI DHFR was isolated from P . mirabilis strain J 120 (pUK672). The cloning vectors used were pUC18 and bacteriophages M13 mp18 and mp19, which were propagated in E. coli K 12 strains JM 103 and JM 101 respectively. '
DNA isolation and purification
Plasmid DNA was purified by use of a Circleprep Kit (Bio 101 Inc., La Jolla, CA, USA) according to the manufacturer's instructions. DNA fragments were purified by separation in, and extraction from, lowmelting-point agarose as previously described. ''
Cloning procedure
All cloning procedures with the vectors pUC 18 and bacteriophages M 13 mp 18 and mp19 were performed according to the methods recommended by the supplier (Boehringer Mannheim). Purified plasmid DNA (pUK672) was partially or fully digested with EcoRI and ligated into suitably restricted plasmid pUC18 with T4 DNA ligase. The hybrid plasmids were transformed into competent E. coli K12 JM103 and clones containing the DHFR gene were selected on a medium containing trimethoprim lactate (Wellcome) 100 mg/L, ampicillin 100 mg/L, isopropyl-B-Dgalactoside and 5-bromo-4-chloro-3-indolyl-~-~-ga~-actopyranoside (X-gal). Plasmid DNA from each clone was screened by the method of Maniatis et al. I2 Similarly, DNA fragments from plasmid pUK672 were ligated with suitably digested replicative form bacteriophage DNA and transformed into E. coZi K 12 JM101.
Sequence determination
Sequencing was performed by the chain termination method of Sanger et aZ.I3 with an M13 sequencing kit (Boehringer) according to the manufacturer's instructions. The sequence was determined from both strands with the exception of c. 200 bp at the 5' end, the sequence of which was determined from one strand only. The sequence around the HindIII restriction site was confirmed with a 20-bp oligonucleotide primer which was complementary to the negative strand of the insert from position 266-285. The sequence was analysed with the Mount sequence analysis package (Genetics Software Centre, Department of Molecular and Cellular Biology, Biosciences West, University of Arizona, Tuscon, AZ 85721, USA).
Results and discussion
Isolation of the type VI DHFR gene
After partial digestion with EcoRI, the plasmid pUK672 was ligated with suitably restricted pUC18 and the hybrid plasmid was transformed into E. coli K12 JM 103. A clone expressing trimethoprim resistance was found to contain a vector plasmid with an insert of c. 9.0 kb. The insert DNA was excised from the vector, purified and digested a second time with EcoRI. The fragments were recloned into pUC18. Clones expressing trimethoprim resistance were screened and the vector with the smallest insert (c. 1.5 kb) was identified. Attempts to remove the c. 1-5-kb fragment from the plasmid revealed that the internal EcoRI site and the adjacent XbaI site of the vector had been damaged. However, the PstI site was functional and was used together with the second EcoRI site to remove the insert.
Digestion of the c. 1.5-kb insert with a number of restriction enzymes showed that single sites for both XbaI and HindIII were present and that the fragments generated by each enzyme were large enough to contain the DHFR gene. These fragments were cloned into pUC18, but only the PstIIXbaI insert expressed trimethoprim resistance. This insert, which was c. 1.0 kb in size, also contained the HindIII site. The biochemical properties of the enzyme expressed by this gene were identical to those expressed by the gene in P. mirubilis J 120.
For sequencing, three fragments were cloned into bacteriophages M13 mp18 and mp19. These were the c. 1-0-kb PstIIXbaI fragment, the c. 600-bp PstI/ HindIII fragment and the c. 400-bp HindIII/XbuI fragment ( fig. 1 ). of 253 E. coli promoters, found that the optimum distance between the -35 and -10 regions was 17 f 1 bp. Taking this into consideration, the hexamer -AGAAAT-, which was 18-bp downstream from the proposed -35 sequence, could have formed the -10 region. However, this sequence differed in three of the six base pairs found most commonly in E. coli -10 sequences, -TATAAT-. If these regions did function as the RNA polymerase binding site, they were further upstream than expected. However, longer leader sequences have been noted previously although their function is not There was a ribosomal binding site (-AGGA-) at an appropriate distance from the proposed initiation codon. '
A possible transcription termination site was present downstream of the coding region. An inverted repeat sequence centred at position 845/6 could be involved in the formation of a stem and loop structure in which the stem contains 8 bp and the loop 16 bases.
Other features consistent with rho-independent termination were not present.
Comparison of amino-acid sequences
The types I, V and VI DHFR genes encode polypeptides of 157 amino acids, whereas the gene for the E. coli chromosomal DHFR encodes a polypeptide of 1 59 residues. ' * These sequences are aligned in fig. 3 and numbered according to the E. coli DHFR. Overall amino-acid homology between the type I and type VI enzymes was 63%, but within the first 50 amino acids, where co-enzyme, substrate and inhibitor binding take place,lg there was 80% homology. There was even greater identity (86.6%) in the residues 51-65. Similarly, comparison of the typeV and typeVI sequences showed 61% homology; 78% of the first 50 residues and 86.6% of residues 5 1-65 were identical. DHFR of E. coli K 12 and the type VI DHFR was only 31%.
The residues known to be involved in folate binding are 5,6,7, 15,20,22,28,30,31 and 94.20 The resistant DHFRs have residues identical to those of E. coli K12 DHFR at positions 5,7,22,31 and 94. The remaining five amino acids differ from those of the E. Coli K12 enzyme, but the substituted residues (Met-6, Ile-20, Glu-27, Gln-28 and Leu-30) are identical in each of the resistant DHFRs. Similarly, residues associated with methotrexate binding in E. coli are : Ile-5, Ala-7, Asp-27, Leu-28, Phe-3 1, Ser-49, Ile-50, Leu-54, Arg-57, Ile-94 and Thr-113.1992' Only five of these 11 residues were conserved in the resistant DHFRs. These substitutions may explain why the binding affinities of the resistant DHFRs and the chromosomal enzyme differ.
Although the similarity in gene length, DNA and amino-acid homology between type I, type V and type VI DHFRs suggests common ancestry, the biochemical properties of these enzymes were distinct. The type V and type VI DHFRs do, however, have certain physical characteristics in common. By Sephadex column chromatography, the mol. wt of the type V DHFR was estimated to be 5000, 8 whereas the gene sequence data showed the mol. wt of the polypeptide to be 17 531.' Similarly, the mol. wt of the typeVI DHFR was estimated to be 100009 whereas the gene determined a polypeptide of over 17 000. The reason for this behaviour is unknown, but it could be due to the hydrophobicity of the enzyme molecules. 22 The mol. wt of the type V DHFR was subsequently reported to be 35 000 by native polyacrylamide gel electrophoresis (PAGE)23 indicating that, like the type I DHFRs, the type V enzyme functions as a dimer. The mol. wt of the type VI DHFR, as assessed by SDS-PAGE, was 17 500. It has not yet been determined whether it functions as a dimer, but the similarities between these three enzymes support this possibility.
